Free Trial

Lucid Diagnostics (LUCD) Insider Trading & Ownership

Lucid Diagnostics logo
$1.28 +0.02 (+1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$1.27 -0.01 (-0.39%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics (NASDAQ:LUCD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.80%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$102K
Number Of
Insiders Selling
(Last 12 Months)
0
Get LUCD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lucid Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LUCD Insider Buying and Selling by Quarter

Lucid Diagnostics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/20/2025Dennis MatheisDirectorBuy100,000$1.02$102,000.00  
(Data available from 1/1/2013 forward)

LUCD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lucid Diagnostics includes Dennis Matheis, and Stanley Lapidus. Learn more on insiders at LUCD.

6.80% of Lucid Diagnostics stock is owned by insiders. Learn more on LUCD's insider holdings.

The following insider purchased LUCD shares in the last 24 months: Dennis Matheis ($102,000.00).

Insiders have purchased a total of 100,000 LUCD shares in the last 24 months for a total of $102,000.00 bought.

The following insider sold LUCD shares in the last 24 months: Stanley Lapidus ($5,820.65).

Insiders have sold a total of 4,017 Lucid Diagnostics shares in the last 24 months for a total of $5,820.65 sold.

Lucid Diagnostics Key Executives

  • Dr. Lishan Aklog M.D. (Age 58)
    Chairman & CEO
    Compensation: $300k
  • Mr. Shaun M. O'Neill M.B.A. (Age 41)
    President & COO
    Compensation: $162.5k
  • Mr. Dennis M. McGrath CPA (Age 67)
    Chief Financial Officer
    Compensation: $225k
  • Mr. Michael Adam Gordon (Age 49)
    General Counsel & Secretary
    Compensation: $250k
  • Dr. Sanford D. Markowitz M.D.
    Ph.D., Cofounder & Strategic Advisor, Member of the Medical Advisor Board
  • Dr. Joseph Willis M.D.
    Cofounder, Strategic Advisor & Member of Medical Advisory Board
  • Dr. Amitabh Chak M.D.
    Cofounder, Strategic Advisor & Member of Medical Advisory Board
  • Richard D. Yazbeck
    Chief Technology Officer
  • Dr. Suman M. Verma M.D.
    Ph.D., Chief Scientific Officer
  • Dr. Brian J. deGuzman M.D. (Age 59)
    Chief Compliance Officer


This page (NASDAQ:LUCD) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners